Actualizado
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Enfermedades infecciosas 2025BASE DE CONOCIMIENTOS MÉDICOS
Recomendaciones clínicas
Consulte las recomendaciones oficiales, los consensos y las actualizaciones publicados por las sociedades médicas y las autoridades sanitarias.
Fuentes oficiales y fiablesSociedades médicas y autoridades sanitarias
Información actualizadaVigilancia científica continua
Acceso gratuito para profesionalesAl servicio de la comunidad médica
APLICACIÓN ASEM
Orientación clínica, estés donde estés
Consulta recomendaciones médicas oficiales y guías de práctica clínica en la app ASEM.
Descargar la app ASEMPublicaciones y actualizaciones importantes
Ver publicaciones recientes
Actualizado
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Cardiología 2025
Publicación oficial
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
Pediatría 2026Todas las recomendaciones (524 resultados)
Filtros
Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) [2022-03-11]”. NACI recomme...
Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax CO...
Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6...
Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Summary of NACI statement of April 5, 2022: Initial guidance on a second booster dose of COVID...
Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 36: Initial guidance on a second booster dose of COVID-19 vaccines in Canada [2022-04-05]”. NACI i...
Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID...
Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 37: Updated guidance on a first booster dose of COVID-19 vaccines in Canada [2022-04-12]”. NACI up...
Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron...
Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01]”...
Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a...